# Endocrinology * **Definition:** The branch of medicine that deals with the endocrine system, its hormones, and related diseases. * **Taxonomy:** Specialties / Endocrinology ## News * Selected news on the topic of **Endocrinology**, for healthcare technology leaders * 3.5K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/26/2025 | [**Can Endocrine NP Training Help Ease Provider Shortage?**](https://www.medscape.com/viewarticle/can-endocrine-np-training-help-ease-provider-shortage-2025a1000d9w) | [[Medscape]] | | 5/20/2025 | [**Telemedicine improves access to endocrinology care for rural patients, study finds**](https://medicalxpress.com/news/2025-05-telemedicine-access-endocrinology-rural-patients.html) | [[MedicalXpress]] | | 4/8/2025 | [**The Inner Circle acknowledges, Sabrina Rene, MD, FACE as a Pinnacle Professional Member**](https://finance.yahoo.com/news/inner-circle-acknowledges-sabrina-rene-214800786.html) | [[Yahoo Finance]] | | 2/12/2025 | [**Comprehensive 25-year history of electronic health records and their role in medical research assembled**](https://medicalxpress.com/news/2025-02-comprehensive-year-history-electronic-health.html) | [[MedicalXpress]] | | 2/12/2025 | [**OsteoStrong® Study Accepted for Publication in The Journal of Clinical Endocrinology ...**](https://www.prnewswire.com/news-releases/osteostrong-study-accepted-for-publication-in-the-journal-of-clinical-endocrinology--metabolism-jcem-302374398.html) | [[PR Newswire]] | | 1/30/2025 | [**The Inner Circle acknowledges, Rimah A. Sharief, MD, FAAP as a Pinnacle Lifetime Member**](https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-rimah-a-sharief-md-faap-as-a-pinnacle-lifetime-member-302364570.html) | [[PR Newswire]] | | 1/14/2025 | [**Experts Pitch Major Overhaul to How Obesity Is Diagnosed**](https://www.medpagetoday.com/primarycare/obesity/113783) | [[Medpage Today]] | | 1/14/2025 | [**Celltrion unveils strategic vision for advancing its innovative drug pipeline at the 43rd Annual J.P. Morgan Healthcare Conference**](https://www.prnewswire.com/news-releases/celltrion-unveils-strategic-vision-for-advancing-its-innovative-drug-pipeline-at-the-43rd-annual-jp-morgan-healthcare-conference-302351202.html) | [[PR Newswire]] | | 12/21/2024 | [**Discovering the Clinical Trial Patient Recruitment Services Market's Types, Applications, and ...**](https://www.linkedin.com/pulse/discovering-clinical-trial-patient-recruitment-servicesmarkets-wiove) | [[Linkedin]] | | 12/18/2024 | [**VSee Health Awarded Teleradiology Services Agreement with Premier, Inc.**](http://www.businesswire.com/news/home/20241218912145/en/VSee-Health-Awarded-Teleradiology-Services-Agreement-with-Premier-Inc./?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/18/2024 | [**VSee Health Awarded Teleradiology Services Agreement with Premier, Inc.**](http://www.businesswire.com/news/home/20241218912145/en/VSee-Health-Awarded-Teleradiology-Services-Agreement-with-Premier-Inc./?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/16/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2827918) | [[JAMA Network]] | | 12/10/2024 | [**Peptide Synthesis Market to Reach USD 1.12 Billion by 2031, Driven by Advancements in ...**](https://www.prnewswire.com/news-releases/peptide-synthesis-market-to-reach-usd-1-12-billion-by-2031--driven-by-advancements-in-drug-development-and-rising-demand-for-therapeutics---market-research-intellect-302327808.html) | [[PR Newswire]] | | 12/2/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2827395) | [[JAMA Network]] | | 11/22/2024 | [**Active Pharmaceutical Ingredients (API) Global Market Overview 2024-2030: Demand for Affordable Medications and Personalized Medicine Solutions to Bolster the $345+ Billion Industry - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241122689131/en/Active-Pharmaceutical-Ingredients-API-Global-Market-Overview-2024-2030-Demand-for-Affordable-Medications-and-Personalized-Medicine-Solutions-to-Bolster-the-345-Billion-Industry---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/12/2024 | [**Digital health technologies play a transformative role in diabetes management and prevention**](https://www.news-medical.net/news/20241112/Digital-health-technologies-play-a-transformative-role-in-diabetes-management-and-prevention.aspx) | [[News Medical Net]] | | 11/11/2024 | [**The role of digital technology in diabetes prevention and management**](https://medicalxpress.com/news/2024-11-role-digital-technology-diabetes.html) | [[MedicalXpress]] | | 10/3/2024 | [**The Inner Circle acknowledges, Sabrina Rene, MD, FACE as a Pinnacle Professional Member**](https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-sabrina-rene-md-face-as-a-pinnacle-professional-member-302267228.html) | [[PR Newswire]] | | 10/1/2024 | [**Biomea Announces Formation of Global Scientific Advisory Board with 22 World-Renowned Diabetes Experts**](https://markets.businessinsider.com/news/stocks/biomea-announces-formation-of-global-scientific-advisory-board-with-22-world-renowned-diabetes-experts-1033811250) | [[Business Insider Markets]] | | 9/30/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2824134) | [[JAMA Network]] | | 8/13/2024 | [**Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Lignins**](https://www.medpagetoday.com/endocrinology/generalendocrinology/111496) | [[Medpage Today]] | | 7/25/2024 | [**The Inner Circle acknowledges, Sabrina M-Y Rene, MD, FACE as a Pinnacle Professional Member**](https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-sabrina-m-y-rene-md-face-as-a-pinnacle-professional-member-302206875.html) | [[PR Newswire]] | | 6/25/2024 | [**YPrime Research Reveals User-Centric eCOA Technologies as Key to Overcoming Challenges in Endocrinology Clinical Trials**](https://www.globenewswire.com/news-release/2024/06/25/2903713/0/en/YPrime-Research-Reveals-User-Centric-eCOA-Technologies-as-Key-to-Overcoming-Challenges-in-Endocrinology-Clinical-Trials.html) | [[Globe Newswire]] | | 6/3/2024 | [**Telemedicine may increase endocrinology care access for under-resourced patients with diabetes and heart disease**](https://medicalxpress.com/news/2024-06-telemedicine-endocrinology-access-resourced-patients.html) | [[MedicalXpress]] | | 2/10/2021 | [**What it's like to specialize in endocrinology: Shadowing Dr. Correa**](https://www.ama-assn.org/medical-students/specialty-profiles/what-it-s-specialize-endocrinology-shadowing-dr-correa) | [[AMA]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Endocrine Society**: A global organization of scientists and healthcare professionals dedicated to the study of hormones and the treatment of endocrine disorders. - **European Society of Endocrinology**: A leading organization focused on advancing the field of endocrinology through research, education, and advocacy. - **Mayo Clinic**: A renowned healthcare institution recognized for its excellence in various specialties, including endocrinology. - **Abbott Laboratories**: A major pharmaceutical company involved in the development of endocrinology drugs. - **American Association of Clinical Endocrinologists (AACE)**: A professional organization dedicated to the advancement of the practice of endocrinology and the care of patients with endocrine disorders. - **Key Player**: Dr. Ellis, Definition: A board-certified internist specializing in endocrinology, providing personalized and preventive care. - **Matthew T. Drake, MD, PhD**: New chief of the Division of Endocrinology and director of the Metabolic Bone Service at Hospital for Special Surgery, focusing on bone health and research. - **Eli Lilly**: A key player in the endocrinology drugs market, focusing on diabetes and other endocrine disorders. - **Dr. Sabrina Rene**: A recognized endocrinologist specializing in various endocrine disorders, including thyroid cancer and diabetes management. - **DelveInsight**: A market research firm providing insights into rare endocrine disorders and treatment practices. - **Dr. Sabrina Rene, MD, FACE**: A recognized expert in endocrinology with over 24 years of experience, specializing in various endocrine disorders. - **Stanford University**: Conducted research on AI applications in patient communication within endocrinology. - **Circadian Health**: A healthcare provider specializing in virtual-first specialty care, including endocrinology, aiming to enhance access and quality of care for chronic conditions. - **The Lancet Diabetes & Endocrinology Commission**: An organization set to release a new evidence-based definition of obesity, endorsed by 75 medical organizations. - **Dr. Teresa Quattrin**: A pediatric endocrinologist at the University at Buffalo's Jacobs School of Medicine, focusing on clinical trials for conditions like achondroplasia. - **Dr. Rimah A. Sharief, MD, FAAP**: Recognized for contributions to Pediatric Endocrinology, specializing in diabetes management and hormonal imbalances in children. - **Charité**: A leading hospital in Berlin, Germany, known for its advanced medical research and treatment in endocrinology. - **Ascendis Pharma**: A biotechnology company focused on developing innovative therapies for rare endocrine diseases, leveraging its TransCon technology platform. - **Neurocrine Biosciences**: A biopharmaceutical company dedicated to addressing complex conditions like congenital adrenal hyperplasia (CAH) through innovative treatments and education. ### Partnerships and Collaborations - **European Society for Pediatric Endocrinology and European Society of Endocrinology**: Jointly hosted congresses to present research findings and advancements in endocrinology, including studies on growth disorders and diabetes. - **Research collaborations**: Endocrinology researchers are collaborating with tech firms to develop innovative solutions for diabetes management, including continuous glucose monitoring systems. - **Collaboration between tech companies and endocrinology practices**: Partnerships are being formed to integrate advanced technologies such as AI and machine learning into endocrinology practices to enhance patient care and streamline operations. - **World Hormone Day Initiative**: A collaborative effort by the European Society of Endocrinology and the European Hormone and Metabolism Foundation to promote awareness of hormone health globally. - **Reem Hospital and Community Outreach**: Reem Hospital is launching a Diabetes & Endocrinology Center to provide comprehensive services and community outreach programs. - **Research Institutions**: Collaboration among prestigious institutions to develop AI tools for personalizing IVF treatment, which may have implications for endocrinology practices. - **AstraZeneca and Amolyt Pharma**: AstraZeneca's acquisition of Amolyt Pharma aims to leverage its expertise and pipeline in rare endocrinology, particularly in treating hypoparathyroidism. - **St. Jude Lab and PreCheck Health Services**: Hosting a webinar to educate healthcare providers on advancements in genetic testing relevant to endocrinology. - **ACELYRIN's Scientific and Patient Advisory Board**: Provides strategic input for the clinical development of lonigutamab for thyroid eye disease. - **Biomea Fusion's Global Scientific Advisory Board**: Comprises leading experts in diabetes therapeutics to guide the development of disease-modifying agents. - **Circadian Health and Gregg Kimmer**: Kimmer's appointment as CEO is expected to enhance Circadian's integrated virtual care model, which includes endocrinology among other specialties. - **International Consortium for AGP & DTx R&D**: Established to standardize Ambulatory Glucose Profile applications globally and promote international collaboration in diabetes treatment. - **Sparrow Pharmaceuticals and Universities**: Collaborating with the University of Oxford and the University of Sheffield for a Phase 2 clinical study on clofutriben for treating autonomous cortisol secretion. - **Institute for Value-Based Medicine and University of Pittsburgh Medical Center**: Partnering to address cardio-kidney-metabolic disease through integrated, patient-centered care. - **Oncofertility Consortium**: A collaborative network established by Teresa K. Woodruff to support cancer survivors in achieving parenthood. - **University at Buffalo**: Conducting over 200 active clinical trials involving approximately 10,000 participants to improve community health and patient outcomes. - **MDVIP**: Dr. Ellis has joined the MDVIP network to enhance patient care through personalized healthcare experiences. - **Rovia Clinical Research**: A multi-specialty clinical research site network collaborating with healthcare providers and pharmaceutical companies to enhance clinical trial delivery. - **Fangzhou Inc. and Alfasigma Group**: Collaboration to improve Internet healthcare delivery in China, focusing on chronic disease management. - **VSee Health and Federal Bureau of Prisons**: Partnered to provide outpatient specialty medical services through telehealth, enhancing healthcare access for inmates. ### Innovations, Trends, and Initiatives - **Telemedicine in endocrinology**: The rise of telemedicine has transformed how endocrinologists provide care, allowing for remote consultations and monitoring of patients with chronic conditions such as diabetes and thyroid disorders. - **Telemedicine in Endocrinology**: Enhanced access to endocrinology care for rural patients, particularly during the COVID-19 pandemic, improving treatment adherence and patient outcomes. - **Lancet Diabetes & Endocrinology Journal**: A new journal focusing on high-impact research in diabetes and endocrinology, highlighting advancements in treatment and management. - **New Endocrinology Therapies**: Ascendis Pharma is set to launch new rare disease medications, SKYTROFA and YORVIPATH, aimed at addressing endocrine disorders. - **Immunoassay Market Growth**: The immunoassay market is projected to grow significantly, impacting endocrinology diagnostics. - **Emerging Treatments for Rare Disorders**: Advancements in enzyme replacement therapies and hormone replacement therapies for rare endocrine disorders. - **Endocrine-Disrupting Chemicals Research**: Research published in *Endocrinology* suggests that exposure to certain EDCs may lead to early puberty in girls, highlighting the need for regulatory actions. - **eCOA Technologies**: User-centric eCOA solutions are being tailored for endocrinology trials to enhance patient engagement and data quality. - **Artificial Intelligence (AI)**: AI is being utilized to analyze patient data and predict outcomes, helping endocrinologists make more informed decisions regarding treatment plans. - **ECHO Model**: A telementoring initiative aimed at improving diabetes care among rural healthcare providers, showing comparable results to endocrinology specialists. - **AI in Patient Communication**: Research from Stanford University shows AI-generated responses improve patient satisfaction in endocrinology. - **Wearable technology**: The use of wearable devices for continuous glucose monitoring and hormone level tracking is becoming increasingly popular, providing real-time data to both patients and healthcare providers. - **Digital Health Technologies**: Advancements in wearable devices, mobile applications, and telemedicine are enhancing diabetes management and prevention. - **World Hormone Day**: Set for April 24, 2025, to educate the public on hormone health and encourage actionable steps for well-being. - **OsteoStrong® Study**: Groundbreaking research showing significant improvements in bone health for postmenopausal women with osteoporosis, published in The Journal of Clinical Endocrinology & Metabolism. - **Lonigutamab Development**: A monoclonal antibody targeting the IGF-1 receptor, showing promise for treating thyroid eye disease. - **Telehealth Expansion**: Blue Circle Health has expanded its telehealth services for type 1 diabetes to multiple states, addressing care shortages. - **Obesity Diagnosis Framework**: A global commission recommends a nuanced approach to obesity diagnosis, advocating for the use of direct body fat measurements alongside BMI. - **PTH1R Agonists**: Septerna's small molecule agonists show promise in regulating calcium homeostasis and treating hypoparathyroidism, with ongoing Phase 1 trials. ### Challenges and Concerns - **Access to Endocrinology Care**: Limited access due to a shortage of specialists and patient-level barriers, which telemedicine aims to address. - **Endocrinologist Shortage**: Almost 70% of U.S. counties are classified as 'endocrinologist deserts,' indicating a significant shortage of specialists in the field. - **Access to Care**: Disparities in access to endocrinology services, particularly for older adults and minority populations, highlighting the need for further investigation into barriers to care. - **Shortage of Endocrinologists**: The growing public health challenge of diabetes is exacerbated by a shortage of endocrinologists, which the ECHO Model aims to address. - **Regulatory compliance**: Endocrinology practices must navigate complex regulations related to telehealth and data management, which can be challenging and resource-intensive. - **Access to technology**: There is a disparity in access to advanced endocrinology technologies, particularly in underserved areas, which can affect the quality of care provided to patients. - **EHR Burden**: Endocrinology specialists spend significant time on electronic health records, impacting patient care efficiency and highlighting the need for improved documentation processes. - **Patent Expiry**: The expiration of patents for major endocrinology drugs may impact the availability of established treatments. - **Obesity Epidemic**: The rising obesity rates in the U.S. pose significant health risks, necessitating effective prevention and treatment strategies in endocrinology. - **Healthcare Workforce Shortage**: The increasing demand for nurse practitioners in specialty care, including endocrinology, highlights the shortage of primary care physicians. - **Delayed Diagnosis of Rare Disorders**: Patients often experience long delays in receiving appropriate care for rare endocrine disorders, impacting their quality of life. - **Provider Directory Inaccuracies**: A study highlighted persistent inaccuracies in provider directories, affecting patient access to endocrinology care. - **Regulatory Hurdles**: The botanical and plant-derived drugs market faces challenges related to efficacy, safety, and regulatory inconsistencies, impacting the development of treatments for endocrine-related conditions. - **FDA Drug Shortages**: Concerns regarding the availability of diabetes medications, including tirzepatide and GLP-1 receptor agonists. - **Delayed Puberty and Diabetes Risk**: Recent studies indicate a significant association between delayed puberty in boys and an increased risk of developing type 2 diabetes, challenging previous assumptions about its harmlessness. - **Implementation of New Obesity Guidelines**: Challenges related to cost and workforce may hinder the adoption of new recommendations for defining and diagnosing obesity. - **Adrenal Insufficiency Risks**: Long-term use of steroid tablets significantly increases the risk of adrenal insufficiency, necessitating careful management and alternative treatments. - **Insurance Disparities**: Research shows that patients with government insurance are less likely to receive CGMs, raising concerns about equitable access to diabetes management tools. ## Related Topics [[Pediatric Endocrinology]]